Drug profile

The FDA adverse-event record for Propylene Glycol, Glycerin, Salicylic Acid

15 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Propylene Glycol, Glycerin, Salicylic Acid. See the species affected, top reactions, and outcomes below.

15
adverse-event reports
0.0%
death-coded share
Dog
most-reported species
4
Deafness - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
15
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Propylene Glycol, Glycerin, Salicylic Acid

Administration Routes

Auricular (Otic)

Species Affected

Dog 8
Cat 7

Most Affected Breeds

Domestic Shorthair 5
Terrier - Yorkshire 3
Rottweiler 1
Bloodhound 1
Shepherd Dog - German 1
Cat (other) 1
Cat (unknown) 1
Boxer (German Boxer) 1
Poodle - Standard 1

Most Reported Reactions

Deafness 4
Behavioural disorder NOS 3
Vomiting 3
Not eating 3
Weight loss 3
Abnormal radiograph finding 2
Abnormal cytology 2
Ataxia 2
Anisocoria 2
Ear discharge 2
Application site bleeding 2
Decreased appetite 1

Outcome Breakdown

Recovered/Normal
8 (50.0%)
Outcome Unknown
7 (43.8%)
Recovered with Sequela
1 (6.3%)

Propylene Glycol, Glycerin, Salicylic Acid Adverse Event Insights

15 reports name Propylene Glycol, Glycerin, Salicylic Acid; 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredient: Propylene Glycol, Glycerin, Salicylic Acid. Administration route: Auricular (Otic).

By species: Dog (8 reports), Cat (7 reports). By breed: Domestic Shorthair (5), Terrier - Yorkshire (3), Rottweiler (1).

Leading clinical signs: Deafness (4), Behavioural disorder NOS (3), Vomiting (3), Not eating (3). Outcome, 16 coded reports: Recovered/Normal leads at 50.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.